Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC11 Iloprost
D02721 Iloprost (USAN/INN) <US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Pulmonary Antihypertensives
Prostacyclin Vasodilators
Iloprost
D02721 Iloprost (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D02721 Iloprost (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00158 Iloprost
D02721 Iloprost
Hormonal agent
DG01961 Prostaglandin derivative
DG01810 Prostacycline derivative
DG00158 Iloprost
D02721 Iloprost
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostacyclin
PTGIR
D02721 Iloprost (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02721
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02721
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02721
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02721
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG00158 Iloprost
Hormonal agent
DG01961 Prostaglandin derivative
DG01810 Prostacycline derivative
DG00158 Iloprost